Tentative FDA Approval for Generic Version of Taxol

Article

(MIAMI, FL)Ivax, Corporation has received tentative approval from the Food and Drug Administration (FDA) for paclitaxel, a generic form of the cancer drug Taxol, made by Bristol-Myers Squibb Company. However, due to a pending lawsuit and patent litigation against Bristol-Myers, it may be as long as 30 months until Ivax can begin selling the new drug. If Ivax obtains final clearance to sell the generic form of Taxol, it is entitled to 180 days of marketing exclusivity for having been the first to file with the FDA. For more information, visit www.fda.org.

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content